European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

10 EU fundings (€7,445,866): Defining Clinical and Molecular Phenotypes of Multi-Drug Resistance in difficult to treat Rheumatoid Arthritis … BdlYear 2024 EU Research and Innovation programme "Horizon"

Text

Companies House RC000710

01/11/2024 EU funding (€10.7M): IMAGING FOR PATIENT BENEFIT IN ARTHRITIS
03/05/2024 EU funding (€155,559): mRNA regulation of actin binding proteins
18/04/2024 EU funding (€309,768): LEISHBLOCK: Exploring an antileishmanial drug toolbox for blocking pathogen transmission in the sand fly vector.
12/12/2024 EU funding (€7,430,427): Defining Clinical and Molecular Phenotypes of Multi-Drug Resistance in difficult to treat Rheumatoid Arthritis
24/04/2024 EU funding (€7,616,426): Multi-sensor Eversion Robot Towards Intelligent Endoscopic Diagnosis and Therapy

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Queen Mary University of London, London.

Creative Commons License The visualizations for "10 EU fundings (€7,445,866): Defining Clinical and Molecular Phenotypes of Multi-Drug Resistance in difficult to treat Rheumatoid Arthritis …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.